AI assistant
Sending…
Karo Pharma AB — M&A Activity 2017
May 4, 2017
6166_iss_2017-05-04_7e847570-883a-486d-ab55-27d5e8c8dbc1.pdf
M&A Activity
Open in viewerOpens in your device viewer
Karo Pharma - Pfizer Collaboration reaches second milestone
STOCKHOLM, May 4, 2017
Karo Pharma has received a milestone for the RORgamma project amounting to 2 million USD.
"This is the second milestone-payment for RORgamma. Very good news for the project" says Anders Lönner, Chairman of the Board.
For further information, please contact: Henrik Palm, CFO, Telephone +46 70 540 40 14 or E-mail [email protected]
The information in this report is such that Karo Pharma is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, on May 4, 2016 at 3.00 p.m. CET.
More from Karo Pharma AB
AGM Information
2022
May 31
Board/Management Information
2022
May 27
AGM Information
2022
May 2
Share Issue/Capital Change
2022
Apr 19
Share Issue/Capital Change
2022
Apr 19
M&A Activity
2022
Apr 1
M&A Activity
2022
Apr 1
Report Publication Announcement
2022
Mar 23
Capital/Financing Update
2022
Mar 23
Capital/Financing Update
2022
Mar 16